Research desk · GLPGF · Nasdaq
GLPGF Stock
SEC financials, peer compare, and chart. Scores open the matching desk. Research only — not advice.
GALAPAGOS NV · Pharmaceutical Preparations
GALAPAGOS NV financial statements, chart, and peer compare from SEC filings.
GALAPAGOS NV (GLPGF) discovers, develops, or markets pharmaceutical products.
- Market cap
- $3.21B
- P/E
- —
- Op. margin
- 26.53%
- Profit margin
- 28.85%
- FCF margin
- -24.38%
- ROE
- 9.92%
Related Health Care stocks: HRMY stock financials · ACAD stock financials · PTCT stock financials · CORT stock financials · PTGX stock financials
GLPGF financial statements
Each Compare name is its own block of years. Filing lines are SEC reports; P/E and price sit on that name’s TTM column only.
GLPGF stock peer compare
Each bar is that name’s percent vs its last TTM, on one zero line. Zero is unchanged. This ticker is the black bar.
Focus chart
Zero is unchanged vs last TTM. Every name is a percent for the metric you pick.
GLPGF stock peer headlines
Yahoo Finance RSS for GLPGF and the names in Compare.
| Ticker | Date | Headline |
|---|---|---|
| Loading headlines… | ||
GLPGF stock price chart
Overlays follow the Compare table.
GLPGF stock — research snapshot
Screen strengths and watchouts for GLPGF stock from the latest Misprise snapshot.
Strengths
- Operating margin 26.5% — solid operating leverage.
- Profit margin 28.9% — durable bottom-line quality.
- Revenue CAGR 5Y 18.4% — durable top-line compound.
- Debt/equity 0.00 — leverage looks manageable.
- Current ratio 20.15 — liquidity cushion.
Watchouts
- Negative FCF margin — cash generation is under pressure.
- Rev CAGR 5Y 18.4%
- Rev CAGR 3Y 66.4%
- EPS CAGR 5Y —
- EPS CAGR 3Y —
- FCF CAGR 5Y -10.4%
- FCF CAGR 3Y -19.9%
GLPGF stock FAQs
Short answers for GLPGF stock — statements, sector, and how this page is meant to be used.
What is GLPGF stock?
GALAPAGOS NV (GLPGF) discovers, develops, or markets pharmaceutical products. GLPGF stock sits in Health Care (Pharmaceutical Preparations), listed on Nasdaq.
Where can I find GALAPAGOS NV financial statements?
GALAPAGOS NV financial statements — income statement, balance sheet, and cash flow — are on this GLPGF stock page, parsed from SEC 10-K and 10-Q filings. Use Annual or Quarterly, then the statement tabs. Research only.
What happened to GLPGF stock?
This page is a research snapshot of GALAPAGOS NV (GLPGF) from the latest SEC filings in the Misprise database as of FY2025. It is not a news feed or a delisting notice. Open the financial statements, chart, and peer compare below, then read the filings. Research only — not financial advice.
Does this page show the GLPGF stock price?
The live chart on this GLPGF stock page is the same TradingView chart as the screener. Statement tables use SEC filings. Any price or multiple on the TTM column is a market snapshot from the last seed, not a real-time quote. Research only.
What sector is GLPGF stock in?
GALAPAGOS NV is classified in Pharmaceutical Preparations, inside the Health Care sector, and trades on Nasdaq. This page is a research snapshot, not a full company profile.
How do I read GLPGF financial statements?
Start with this ticker’s block (TTM, then its fiscal years or quarters). Each Compare name is a separate block of its own periods — not mixed by year. A blank is a period we do not have, not a zero. Research only — not a buy or sell.
Where does the GLPGF statement data come from?
Income, balance sheet, and cash-flow lines are parsed from SEC company filings (10-K / 10-Q and 20-F). TTM is the last four reported quarters added together, not a separate filing. P/E, forward P/E, price, and market cap are a market quote at last seed — trailing P/E from the quote when available, otherwise last price divided by TTM EPS. They are not 10-K line items and appear on the TTM column only. Research only — not financial advice.
Where can I find the GLPGF income statement, balance sheet, and cash flow?
On this GLPGF stock page, open Financial statements and use the Income, Balance sheet, and Cash flow tabs. Growth and valuation sit under More. Filing figures are from SEC reports; valuation multiples are the market snapshot described above.
What is the Misprise Score for GLPGF stock?
GLPGF stock currently scores 51/100 (Watch / incomplete (<60)). GALAPAGOS NV scores weaker or incomplete on durable growth/quality inputs — leverage, coverage, and recent results deserve extra scrutiny. The score is a screen of quality, growth, and balance-sheet inputs — not a price target. Compare it in the Misprise screener; it is not a separate score page.
How is the GLPGF comparison winner decided?
Lead and Tie follow the number printed on each factor row, not a blended category score. Growth, quality, score, current ratio, and coverage: the higher figure leads. Value multiples (P/E, PEG, P/B, P/S) and debt ratios: the lower figure leads. Tie appears only when those printed numbers match. The header winner is whoever takes more of those five rows. CAGR uses the 5-year horizon and drops to 3-year only when both names report it. Research only — not a buy or sell.
What is the Anomaly Score on this GLPGF page?
Anomaly Score is how unusual a filing pattern is versus this company’s own history and its industry — not the same as Misprise Score. A high anomaly with a weak Misprise Score is often a noisy name. Open the anomaly detector to see the flag. Research only — not financial advice.
What does the green grant dot mean on GLPGF stock?
A green circle next to the title means this ticker appears in the Misprise grants calendar with a recent federal award (USASpending / SAM). Tap the dot for date, agency, and amount when available. It is a research flag only — not a buy or sell signal.
Is GLPGF stock a buy?
No recommendation either way. This GLPGF stock page organizes statements, ratios, and peers so you can do your own work. It is educational only — not advice to buy or sell GALAPAGOS NV.